Larissa C. Lago
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Serotonergic-dependent effects of exercise and elevated stress hormone on small non-coding RNA transcriptomics and proteomics in a mouse model of affective disorders.
Journal: Neuropharmacology
Published: July 17, 2024
Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: October 10, 2023
Characterization of the spatial distribution of metals and profile of metalloprotein complexes in a mouse model of repetitive mild traumatic brain injury.
Journal: Metallomics : integrated biometal science
Published: July 24, 2022
Correction to: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 15, 2021
Quantitative Phosphoproteomics Reveals Extensive Protein Phosphorylation Dysregulation in the Cerebral Cortex of Huntington's Disease Mice Prior to Onset of Symptoms.
Journal: Molecular neurobiology
Published: October 03, 2021
Differential protein expression due to Se deficiency and Se toxicity in rat liver.
Journal: The Journal of nutritional biochemistry
Published: February 07, 2021
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.
Journal: Journal of Alzheimer's disease : JAD
Published: November 30, 2020
Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: November 12, 2020
Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease.
Journal: Brain communications
Published: November 05, 2020
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.
Journal: Journal of Alzheimer's disease : JAD
Published: August 04, 2020
Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy.
Journal: Metallomics : integrated biometal science
Published: January 07, 2020
Choice of mobile phase: Implications for size exclusion chromatography-inductively coupled plasma-mass spectrometry analyses of copper, zinc and iron metalloproteins.
Journal: Journal of chromatography. A
Published: October 22, 2019
Last Updated: 09/26/2026